DBV Technologies | Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amarin USD -8.12M 5.34M 2025-09
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
DBV Technologies USD -33.16M 8.6M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Incyte USD 482.31M 75.7M 2025-09
Insmed USD -368.7M 48.26M 2025-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
United Therapeutics USD 438M 29.6M 2025-09


DBV Technologies Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.